Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Azam Safary

19PUBLICATIONS

14CO-AUTHORS

AutoimmunityChemotherapyMolecular targetsGenomics and transcriptomicsAutonomic nervous system

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (19)

Sort by Publication Date:

|Jul 03, 2025

Interleukin-17 and interleukin-23 cytokine profiles in palindromic rheumatism: potential therapeutic targets and prognostic biomarkers for disease progression to rheumatoid arthritis.

Kamran Javidi-Aghdam, Mostafa Akbarzadeh-Khiavi, Arezoo Ghasembaglou

|Jun 30, 2025

Anticancer impacts of the unicellular cyanobacterium <i>Chroococcus turgidus</i> bioactive compounds in colorectal adenocarcinoma.

Hamieh Goshtasbi, Azam Safary, Ali Movafeghi

|Jan 09, 2025

EGFR-targeting RNase A-cetuximab antibody-drug conjugate induces ROS-mediated apoptosis to overcome drug resistance in KRAS mutant cancer cells.

Bita Jafary, Mostafa Akbarzadeh-Khiavi, Hamed Farzi-Khajeh

|Jan 08, 2025

Role of NEAT1 and HOTAIR long non-coding RNAs in Behcet's Disease pathogenesis and their correlation with target inflammatory cytokines.

Kamran Javidi-Aghdam, Amirhossein Faghfouri, Mehdi Jafarpour

|Oct 19, 2024

Immunoregulatory role of AC007278.3 and HOTAIR long non-coding RNAs in lupus nephritis: potential biomarkers and therapeutic targets.

Elahe Rasuli, Kamran Javidi-Aghdam, Mostafa Akbarzadeh-Khiavi

|Feb 08, 2024

Targeting long non-coding RNAs as new modulators in anti-EGFR resistance mechanisms.

Mostafa Akbarzadeh-Khiavi, Azam Safary, Yadollah Omidi

Pageof 4

Frequent Collaborators

9 joint publications

Mostafa Akbarzadeh-Khiavi

6 joint publications

Yadollah Omidi

5 joint publications

Jaleh Barar

4 joint publications

Alireza Khabbazzi

4 joint publications

Leila Rahbarnia

1 joint publications

Mohammad Hossein Somi

1 joint publications

Marziyeh Fathi

1 joint publications

Mohammad Hossein Somi

1 joint publications

Hakimeh Moghaddas-Sani

1 joint publications

Mohammad A Rafi

Frequent Collaborators

9 joint publications

Mostafa Akbarzadeh-Khiavi

6 joint publications

Yadollah Omidi

5 joint publications

Jaleh Barar

4 joint publications

Alireza Khabbazzi

Top Related Videos

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on : Sep 26, 2013

Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells

Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells

Published on : Jun 13, 2020

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

See more related videos

Top Related Videos

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on : Sep 26, 2013

Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells

Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells

Published on : Jun 13, 2020

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

See more related videos